1 von Haehling S, Arends J, Hacker U, Blum D. Kachexie bei Tumorerkrankungen - Erkennen und multimodal behandeln. Kachexie bei Tumorerkrankungen. München: Springer Medizin Verlag GmbH; 2017.
DOI: 10.1007/978-3-89935-305-1.
2 von Haehling S, Anker SD. Cachexia as a major underestimated and unmet medical need: Facts and numbers. J Cachexia Sarcopenia Muscle. 2010;1(1):1–5.
DOI: 10.1007/s13539-010-0002-6.
3 Farkas J, von Haehling S, Kalantar-Zadeh K, Morley JE, Anker SD, Lainscak M. Cachexia as a major public health problem: Frequent, costly, and deadly. J Cachexia Sarcopenia Muscle. 2013;4(3):173–8.
DOI: 10.1007/s13539-013-0105-y.
4 Argilés JM, Busquets S, Stemmler B, López-soriano FJ. Cancer cachexia: understanding the molecular basis. Nat Publ Gr. 2014;14(11):754–62.
DOI: 10.1038/nrc3829.
5 Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, et al. Definition and classification of cancer cachexia: An international consensus. Lancet Oncol. 2011;12(5):489–95.
DOI: 10.1016/S1470-2045(10)70218-7.
6 Hopkinson JB, Wright DNM, McDonald JW, Corner JL. The Prevalence of Concern About Weight Loss and Change in Eating Habits in People with Advanced Cancer. J Pain Symptom Manage. 2006;32(4):322–31.
DOI: 10.1016/j.jpainsymman.2006.05.012.
7 Bruggeman AR, Kamal AH, LeBlanc TW, Ma JD, Baracos VE, Roeland EJ. Cancer Cachexia: Beyond Weight Loss. J Oncol Pract. 2016;12(11):1163–71.
DOI: 10.1200/jop.2016.016832.
8 von Haehling S, Anker SD. Prevalence, incidence and clinical impact of cachexia: facts and numbers—update 2014. J Cachexia Sarcopenia Muscle. 2014;5(4):261–3.
DOI: 10.1007/s13539-014-0164-8.
9 Constantinou C, Cristine C, Oliveira FDE, Mintzopoulos D, Busquets S, He J, et al. Nuclear magnetic resonance in conjunction with functional genomics suggests mitochondrial dysfunction in a murine model of cancer cachexia. Int J Mol Med. 2011;27:15–24.
DOI: 10.3892/ijmm.2010.557.
10 Tsoli M, Robertson G. Cancer cachexia: malignant inflammation, tumorkines, and metabolic mayhem. Trends Endocrinol Metab. 2013;24(4):174–83.
DOI: 10.1016/j.tem.2012.10.006.
11 Aapro M, Arends J, Bozzettim F, Fearon K, Grunberg SM, Herrstedt J, et al. Early recognition of malnutrition and cachexia in the cancer patient: A position paper of a european school of oncology task force. Ann Oncol. 2014;25(8):1492–9.
DOI: 10.1093/annonc/mdu085 LK.
12 Fearon K. Cancer cachexia: Developing multimodal therapy for a multidimensional problem. Eur J Cancer. 2008;44(8):1124–32.
DOI: 10.1016/j.ejca.2008.02.033.
13 Schuetz P, Fehr R, Baechli V, Geiser M, Deiss M, Gomes F, et al. Individualised nutritional support in medical inpatients at nutritional risk: a randomised clinical trial. Lancet. 2019;393(10188):2312–21.
DOI: 10.1016/S0140-6736(18)32776-4.
14 Arends J, Baracos V, Bertz H, Bozzetti F, Calder PC, Deutz NEP, et al. ESPEN expert group recommendations for action against cancer-related malnutrition. Clin Nutr. 2017;36(5):1187–96.
DOI: 10.1016/j.clnu.2017.06.017.
15 Pautex S, Genton L. Indications à la nutrition artificielle chez les patients en soins palliatifs. Forum Med Suisse. 2019;19(49–50):800–2.
DOI: 10.4414/smf.2019.08409.
16 Bundesärztekammer. Grundsätze der Bundesärztekammer zur ärztlichen Sterbebegleitung. 2011;108:346–8.
17 Hopkinson JB. Psychosocial impact of cancer cachexia. J Cachexia Sarcopenia Muscle. 2014;5(2):89–94. DOI: 10.1007/s13539-014-0142-1
18 Gottschling S, Welsch K. Übers Sterben reden. 1st ed. Frankfurt am Main: Fischer Taschenbuch; 2019.
19 Pfaffenberger RS, Hyde RT, Wing AL, Hsieh C-C. Physical activity, all-cause mortality, and longevity of college alumni. N Engl J Med. 1986;314(10):605–13.
20 Buffart LM, Kalter J, Sweegers MG, Courneya KS, Newton RU, Aaronson NK, et al. Effects and moderators of exercise on quality of life and physical function in patients with cancer: An individual patient data meta-analysis of 34 RCTs. Cancer Treat Rev. 2017;52:91–104.
DOI: 10.1016/j.ctrv.2016.11.010.
21 Solheim TS, Fearon KCH, Blum D, Kaasa S. Non-steroidal anti-inflammatory treatment in cancer cachexia: A systematic literature review. Acta Oncol (Madr). 2013;52(1):6–17.
DOI: 10.3109/0284186X.2012.724536.
22 Ruiz Garcia V, López-Briz E, Carbonell Sanchis R, Gonzalvez Perales J, Bort-Martí S. Megestrol acetate for treatment of anorexia-cachexia syndrome. Cochrane Database Syst Rev. 2013;(3). DOI: 10.1002/14651858.CD004310.pub3.
23 Garcia JM. What’s Next After Anamorelin? Curr Opin Support Palliat Care. 2018;11(4):266–71.
DOI: 10.1097/SPC.0000000000000299.
24 Bennani-Baiti N, Walsh D. What is cancer anorexia-cachexia syndrome? A historical perspective. J R Coll Physicians Edinb. 2009;39:257–262.
25 Baracos VE, Mazurak VC, Bhullar AS. Cancer cachexia is defined by an ongoing loss of skeletal muscle mass. Ann Palliat Med. 2019;8(1):3–12.
DOI: 10.21037/APM.2018.12.01.
26 Peixoto da Silva S, Santos JMO, Costa e Silva MP, Gil da Costa RM, Medeiros R. Cancer cachexia and its pathophysiology: links with sarcopenia, anorexia and asthenia. J Cachexia Sarcopenia Muscle. 2020;
DOI: 10.1002/jcsm.12528.
27 Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31.
DOI: 10.1093/ageing/afy169.
28 Rhondali W, Chisholm GB, Daneshmand M, Allo J, Kang DH, Filbet M, et al. Association between body image dissatisfaction and weight loss among patients with advanced cancer and their caregivers: A preliminary report. J Pain Symptom Manage. 2013;45(6):1039–49. DOI: 10.1016/j.jpainsymman.2012.06.013.
29 Strasser F, Binswanger J, Cerny T, Kesselring A. Fighting a losing battle: Eating-related distress of men with advanced cancer and their female partners. A mixed-methods study. Palliat Med. 2007;21(2):129–37.
DOI: 10.1177/0269216307076346.
30 Vagnildhaug OM, Brunelli C, Hjermstad MJ, Strasser F, Baracos V, Wilcock A, et al. A prospective study examining cachexia predictors in patients with incurable cancer. BMC Palliat Care. 2019;18(1):1–10.
DOI: 10.1186/s12904-019-0429-2.
31 Merker M, Felder M, Gueissaz L, Bolliger R, Tribolet P, Kägi-Braun N, et al. Association of Baseline Inflammation With Effectiveness of Nutritional Support Among Patients With Disease-Related Malnutrition: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw open. 2020;3(3):e200663.
DOI: 10.1001/jamanetworkopen.2020.0663.
32 Dabiri S, Popuri K, Ma C, Chow V, Feliciano EMC, Caan BJ, et al. Deep learning method for localization and segmentation of abdominal CT. Comput Med Imaging Graph [Internet]. 2020;85:101776. DOI:
https://doi.org/10.1016/j.compmedimag.2020.101776.
33 Solheim TS, Laird BJA, Balstad TR, Stene GB, Bye A, Johns N, et al. A randomized phase II feasibility trial of a multimodal intervention for the management of cachexia in lung and pancreatic cancer. J Cachexia Sarcopenia Muscle. 2017;8(5):778–88.
DOI: 10.1002/jcsm.12201.